Sacubitril/valsartan in heart failure with mildly reduced or preserved ejection fraction: a pre-specified participant-level pooled analysis of PARAGLIDE-HF and PARAGON-HF

AIMS: The PARAGLIDE-HF trial demonstrated reductions in natriuretic peptides with sacubitril/valsartan compared with valsartan in patients with heart failure (HF) with mildly reduced or preserved ejection fraction who had a recent worsening HF event, but was not adequately powered to examine clinica...

Descripción completa

Detalles Bibliográficos
Autores principales: Vaduganathan, Muthiah, Mentz, Robert J, Claggett, Brian L, Miao, Zi Michael, Kulac, Ian J, Ward, Jonathan H, Hernandez, Adrian F, Morrow, David A, Starling, Randall C, Velazquez, Eric J, Williamson, Kristin M, Desai, Akshay S, Zieroth, Shelley, Lefkowitz, Martin, McMurray, John J V, Braunwald, Eugene, Solomon, Scott D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Fast Track Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10424880/
https://www.ncbi.nlm.nih.gov/pubmed/37210743
http://dx.doi.org/10.1093/eurheartj/ehad344

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10424880/
https://www.ncbi.nlm.nih.gov/pubmed/37210743
http://dx.doi.org/10.1093/eurheartj/ehad344

Ejemplares similares